Loco-Regional Therapies in Oligometastatic Adrenocortical Carcinoma

Loco-Regional Therapies in Oligometastatic Adrenocortical Carcinoma

Objective: The recommended first-line treatment for low-tumor-burden ACC (stage IVa ACC) not amenable to radical resection is mitotane in association with loco-regional treatments (LRs). The aim of this study was to determine the patient population that would benefit the most from LR. Materials and...

Full description

Bibliographic Details
Main Authors: Charles Roux, Alice Boileve, Matthieu Faron, Livia Lamartina, Alexandre Delpla, Lambros Tselikas, Jérome Durand-Labrunie, Segolène Hescot, Thierry de Baere, Julien Hadoux, Frederic Deschamps, Eric Baudin
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Cancers
Subjects:
adrenocortical carcinoma
loco-regional treatments
oligometastatic
prognosis factors
interventional radiology
Online Access:https://www.mdpi.com/2072-6694/14/11/2730

Internet

https://www.mdpi.com/2072-6694/14/11/2730

Similar Items